Full text is available at the source.
The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1
The CXCL12/CXCR4 pathway may cause resistance to temozolomide in human glioblastoma cells by increasing FOXM1 levels
AI simplified
Abstract
The CXCL12/CXCR4 axis enhances temozolomide resistance in glioblastoma cells.
- CXCL12/CXCR4 is associated with increased drug resistance in glioblastoma multiforme (GBM).
- This axis promotes cell migration and invasion in GBM cells.
- FOXM1 is up-regulated by CXCL12/CXCR4, contributing to TMZ resistance.
- Suppressing CXCL12/CXCR4 and silencing FOXM1 partially reverses drug resistance.
AI simplified